Risk factors, management and outcomes of patients admitted with near fatal asthma to a tertiary care hospital in Riyadh

dc.contributor.authorAl-Dorzi, Hasan M.
dc.contributor.authorAl-Shammary, Haifa
dc.contributor.authorAl-Shareef, Salha
dc.contributor.authorTamim, Hani Mohammed
dc.contributor.authorShammout, Khaled
dc.contributor.authorAl-Dawood, Abdulaziz S.
dc.contributor.authorArabi, Yaseen M.
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:43:02Z
dc.date.available2025-01-24T11:43:02Z
dc.date.issued2014
dc.description.abstractRationale: Near-fatal asthma (NFA) has not been well studied in Saudi Arabia. We evaluated NFA risk factors in asthmatics admitted to a tertiary-care hospital and described NFA management and outcomes. Materials and Methods: This was a retrospective study of NFA patients admitted to an ICU in Riyadh (2006-2010). NFA was defined as a severe asthma attack requiring intubation. To evaluate NFA risk factors, randomly selected patients admitted to the ward for asthma exacerbation were used as controls. Collected data included demographics, information on prior asthma control and various NFA treatments and outcomes. Results: Thirty NFA cases were admitted to the ICU in the five-year period. Compared to controls (N = 120), NFA patients were younger (37.5 ± 19.9 vs. 50.3 ± 23.1 years, P = 0.004) and predominantly males (70.0% vs. 41.7%, P = 0.005) and used less inhaled steroids/long-acting ß2-agonists combination (13.6% vs. 38.7% P = 0.024. Most (73.3%) NFA cases presented in the cool months (October-March). On multivariate analysis, age (odds ratio [OR] 0.96; 95% confidence interval [CI], 0.92-0.99, P = 0.015) and the number of ED visits in the preceding year (OR, 1.25; 95% CI, 1.00-1.55) were associated with NFA. Rescue NFA management included ketamine (50%) and theophylline (19%) infusions. NFA outcomes included: neuromyopathy (23%), mechanical ventilation duration = 6.4 ± 4.7 days, tracheostomy (13%) and mortality (0%). Neuromuscular blockade duration was associated with neuromyopathy (OR, 3.16 per one day increment; 95% CI, 1.27-7.83). Conclusions: In our study, NFA risk factors were younger age and higher number of ED visits. NFA had significant morbidity. Reducing neuromuscular blockade duration during ventilator management may decrease neuromyopathy risk.
dc.identifier.doihttps://doi.org/10.4103/1817-1737.124441
dc.identifier.eid2-s2.0-84892762382
dc.identifier.urihttp://hdl.handle.net/10938/30183
dc.language.isoen
dc.relation.ispartofAnnals of Thoracic Medicine
dc.sourceScopus
dc.subjectAsthma
dc.subjectCritical illness
dc.subjectMechanical ventilation
dc.subjectNeuromyopathy
dc.subjectCisatracurium
dc.subjectCorticosteroid
dc.subjectIpratropium bromide
dc.subjectKetamine
dc.subjectMagnesium sulfate
dc.subjectMethylprednisolone
dc.subjectTheophylline
dc.subjectAdult
dc.subjectArticle
dc.subjectArtificial ventilation
dc.subjectClinical article
dc.subjectControlled study
dc.subjectCorticosteroid therapy
dc.subjectEmergency care
dc.subjectFemale
dc.subjectHuman
dc.subjectIntensive care unit
dc.subjectMale
dc.subjectNear fatal asthma
dc.subjectNeuromuscular blocking
dc.subjectNeuromuscular disease
dc.subjectPhysiotherapy
dc.subjectRetrospective study
dc.subjectRisk factor
dc.subjectSaudi arabia
dc.subjectTertiary care center
dc.subjectTracheostomy
dc.subjectYoung adult
dc.titleRisk factors, management and outcomes of patients admitted with near fatal asthma to a tertiary care hospital in Riyadh
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2014-10930.pdf
Size:
469.12 KB
Format:
Adobe Portable Document Format